FDA approves first generic Strattera for the treatment of ADHD - FDA Press Releases

The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.

from Food and Drug Administration--Press Releases http://ift.tt/2sbn2Hq
via IFTTT